Clinical Trial Update: Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sorafenib in combination with carboplatin and paclitaxel for stage IV ocular melanoma has completed enrollment, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma
• Ciliary Body Melanoma
• Intraocular Melanoma
• Iris Melanoma
• Uveal Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nexavar (Sorafenib)
• Taxol (paclitaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2012-07-11